SANA Competitors & Alternatives

Compare Sana Biotechnology Inc with similar stocks in the same industry

Biotechnology

SANA

Main Stock
$1.90
-5.94%
Tradestie Score
47
Market Cap
$951.83M
Analyst Upside
+343.6%

Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)

Bottleneck Score: 3/10 Drug Discovery Biotech Cell Therapy
Competitive Moat: None
Core Technology Stack: Hypoimmune cell engineering, Fusogen targeted delivery, CRISPR-based gene editing
Major Customers 4
Academic medical centers Clinical trial sites Future specialty hospitals Strategic pharma partners
Critical Suppliers 3
CDMO manufacturing partners Gene editing reagent providers Viral vector suppliers
Direct Ecosystem Rivals 4

Top Competitors

218 stocks in Biotechnology
Company Price Market Cap P/E Score Action
TERN Terns Pharmaceuticals, Inc. Common Stock
$52.95
+0.04%
$683.46M - 49 Compare
ANL ANL
$9.87
-6.97%
$677.47M - 48 Compare
MGTX MeiraGTx Holdings plc Ordinary Shares
$8.83
-3.87%
$665.30M 10.1 46 Compare
ERAS Erasca, Inc. Common Stock
$15.16
-3.22%
$626.91M - 35 Compare
SVRA Savara Inc.
$4.45
-4.20%
$611.84M - 56 Compare
KALV KalVista Pharmaceuticals, Inc. Common Stock
$27.00
+0.04%
$608.81M - 49 Compare
VSTM Verastem, Inc.
$7.90
-3.48%
$541.60M - 54 Compare
CRVS Corvus Pharmaceuticals, Inc.
$10.64
-0.05%
$540.97M - 34 Compare
ZVRA Zevra Therapeutics, Inc. Common Stock
$9.22
+1.49%
$529.35M 9.7 56 Compare
LXRX Lexicon Pharmaceuticals, Inc.
$1.75
-2.51%
$512.39M - 37 Compare

Data updated: Nov 16, 2026 | Industry: Biotechnology (SIC 2836)

218 stocks in this industry